Showing results (71-80 of 158) with videos related to
Sort By:
Pageof 16
Hematology/Oncology Clinics of North America|January 11, 2005
Antiplatelet agents: current drugs and future trendsHarry L Messmore, Walter P Jeske, William Wehrmacher, et al.Journal of Cardiopulmonary Rehabilitation and Prevention|January 24, 2020
High Submaximal Exercise Heart Rate Impacts Exercise Intolerance in the Postural Orthostatic Tachycardia SyndromeErik H Van Iterson, Luke J Laffin, Kenneth A Mayuga, et al.Atherosclerosis|June 6, 2026
Concordance of Lipoprotein(a) measurements in mg/dL and nmol/L: Insights from the Lp(a)HORIZON trialLeslie Cho, Børge G Nordestgaard, Bliss Chang, et al.The American Journal of Cardiology|August 24, 2019
Comparison of Long-Term Clinical Outcomes After Drug-Eluting Stenting in Blacks-vs-WhitesStephen G Ellis, Leslie Cho, Russell Raymond, et al.The American Journal of Cardiology|May 18, 2012
Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgeryAndrew N Rassi, Eugene Blackstone, Michael A Militello, et al.European Heart Journal. Acute Cardiovascular Care|June 8, 2018
Clevidipine as a therapeutic and cost-effective alternative to sodium nitroprusside in patients with acute aortic syndromesCarlos L Alviar, Alejandra Gutierrez, Leslie Cho, et al.The American Journal of Cardiology|October 6, 2024
Chronic Kidney Disease Predisposes to Acute Congestive Heart Failure, Cardiogenic Shock, and Mortality in Patients Undergoing Percutaneous Coronary InterventionMeghana Iyer, Khaled Ziada, Leslie Cho, et al.Journal of the American College of Cardiology|April 20, 2004
Severe bilateral carotid stenosis: the impact of ipsilateral stenting on Doppler-defined contralateral stenosisRavish Sachar, Jay S Yadav, Marco Roffi, et al.Journal of the American Heart Association|October 22, 2014
Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patientsW H Wilson Tang, Eric J Topol, Yiying Fan, et al.Cardiovascular Drugs and Therapy|August 4, 2018
Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension StudiesLeslie Cho, Ricardo Dent, Erik S G Stroes, et al.Pageof 16